|       |       |       |    contact@vittarthaa.com    |    Mobile: +91 96866 23006   |    Corp office: +91 80 35893150 / 35893151, R&D and Mfg facility: +91 80 48527566



Growth
  

 

2021
  • Marketing Department established for FMCG products
  • First batch of Hygiene products manufactured in fully functional facility and launched into the Bangalore market with the following trade name
    • Trefo hygieneTM
  • Expanded the R&D lab with state-of-the-art Imaging facility for Immunohistochemistry, Zebra fish and Caenorhabditis elegans.
  • Received fssai license for manufacture of Nutraceutical products.
  • Received ISO 9001:2015 and HACCP certificates for Manufacturing facility at Bommasandra, Bangalore.
2020
  • First batch of Monoclonal Antibody released to market for research use only
  • Received ISO:13485 Certification
  • Operation and Expansion to manufacturing facility with 3 major Brands:
    • Trefo hygieneTM
    • Ishayu health®
    • Surai’s Luxury personal care®
  • Launch of proprietary discovery product TraigunyaTM used in Immunohistochemistry along with OSB Life Sciences
2019
  • Established Cell KraftTM in collaboration with OSB Life Sciences for marketing of Monoclonal antibodies and critical reagents
  • Established In silico Genotoxicity and Carcinogenicity assessment of impurities in drug manufacturing. Reports successfully submitted to US FDA and MHRA.
  • Operational expansion of F&D facility for Nutraceuticals and Cosmetic products
  • Acquisition of a small Cosmetic firm
2018
  • Established CPCSEA approved Animal facility
  • Established IBSC approved Viral lab
  • Operational expansion of R&D facility for Pharmaceuticals, Nutraceuticals and Cosmetic product discovery and development
  • Collaboration for development of Biologicals and Small molecules
2017
  • Established Research facility at Bangalore for Pre-clinical Biology – Early Discovery and Development.
  • Collaboration with Leucin Rich Bio on Gut Microflora
2016
  • Initiated Vittarthaa operations as Advisory and Consulting firm in Safety assessment for Pharmaceuticals, Drug Discovery and New Product Development